MAM
INDV icon

Melqart Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Melqart Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Sell
585,664
-98,656
-14% -$3.58M 2.29% 14
2026
Q1 		$20.9M Buy
+684,320
New +$22.6M 2.06% 21
2025
Q4 		– Sell
-616,863
Closed -$14.9M – 56
2025
Q3 		$14.9M Buy
616,863
+449,324
+268% +$9.4M 1.98% 20
2025
Q2 		$2.47M Buy
+167,539
New +$1.95M 0.35% 29
2025
Q1 		– Sell
-104,790
Closed -$1.3M – 59
2024
Q4 		$1.3M Buy
104,790
+91,280
+676% +$939K 0.16% 46
2024
Q3 		$132K Buy
+13,510
New +$158K 0.01% 51

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Melqart Asset Management's INDV Position: Q2 2026 in Review

Melqart Asset Management reduced its Indivior Pharmaceuticals (INDV) stake by 14% in Q2 2026, selling an estimated $3.58M and leaving 585,664 shares worth $24M. The position accounts for 2.29% of the portfolio, ranked #14.

Melqart Asset Management first reported a position in INDV in Q3 2024 and has held it in 6 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Melqart Asset Management held 585,664 shares of Indivior Pharmaceuticals worth $24M as of Q2 2026.
  • Melqart Asset Management sold 98,656 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.58M.
  • Indivior Pharmaceuticals made up 2.29% of Melqart Asset Management's portfolio in Q2 2026, its #14 holding.
  • Melqart Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Melqart Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.